Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
ANAB
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
ANAB
AnaptysBio, Inc. Common Stock
52w high -18.5%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
anaptysbio
therapeutics
nasdaq
price
clinical
anaptys
analysts
2024
stage
announces
2023
their
analyst
announced
results
tesaro
biotechnology
agreement
drug
session
StonvexStonvexStonvexStonvex